Barely Significant
← all excerpts

Development of tenecteplase for stroke thrombolysis: Japan's endeavor.

Hypertens Res · 2026 · PMC12960247 · PMID 41136597

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
What about doses lower than 0.25 mg/kg? Although the sample sizes were small and statistical significance was not reached, the 0.20 mg/kg tenecteplase group showed a trend toward favorable outcomes, with odds ratios comparable to those of the 0.25 mg/kg group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.